Saw, Robyn P M <br/><br/>
p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.  [electronic resource] 

 -  Diseases of the colon and rectum  Feb 2003 
 - 192-202 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0012-3706 
<br/><br/><label>Standard No.: </label>10.1007/s10350-004-6524-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--metabolism<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--metabolism<br/>Cell Adhesion Molecules--genetics<br/>Combined Modality Therapy<br/>DCC Receptor<br/>Female<br/>Genes, DCC--genetics<br/>Genes, Tumor Suppressor<br/>Genes, p53--genetics<br/>Humans<br/>Immunoenzyme Techniques<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Polymerase Chain Reaction<br/>Polymorphism, Single-Stranded Conformational<br/>Prognosis<br/>Receptors, Cell Surface<br/>Rectal Neoplasms--metabolism<br/>Survival Rate<br/>Thymidylate Synthase--genetics<br/>Tumor Suppressor Protein p53--genetics<br/>Tumor Suppressor Proteins--genetics